“Artificial Intelligence in Pharmaceutical Care Management for Anxiety, Depression, and Schizophrenia: A Narrative Review” (2025) Pakistan Journal of Medical & Cardiological Review, 4(4), pp. 246–255. doi:10.64105/vytceb34.